Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response
Saved in:
Main Authors: | Laure Marignol, Christopher William Pugh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000290.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
by: Brian M Ortmann
Published: (2024-07-01) -
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
by: Laura M. S. Seeber, et al.
Published: (2010-01-01) -
Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α
by: Xiawa Mao, et al.
Published: (2021-01-01) -
Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia
by: Korry J. Hintze, et al.
Published: (2011-01-01) -
Relationship between inherited genetic variation and survival from colorectal cancer stratified by tumour location
by: Christopher Wills, et al.
Published: (2025-01-01)